Brooklyn Investment Group Acquires 3,812 Shares of Haleon plc (NYSE:HLN)

Brooklyn Investment Group lifted its holdings in shares of Haleon plc (NYSE:HLN) by 168.1% during the 4th quarter, Holdings Channel reports. The firm owned 6,080 shares of the company’s stock after purchasing an additional 3,812 shares during the quarter. Brooklyn Investment Group’s holdings in Haleon were worth $58,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Fortitude Family Office LLC acquired a new stake in shares of Haleon in the 3rd quarter valued at about $28,000. Versant Capital Management Inc grew its stake in Haleon by 2,029.1% in the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock valued at $34,000 after acquiring an additional 3,348 shares during the period. Toronto Dominion Bank increased its holdings in shares of Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock valued at $38,000 after acquiring an additional 3,470 shares in the last quarter. Prospera Private Wealth LLC acquired a new position in shares of Haleon during the third quarter worth approximately $57,000. Finally, Hexagon Capital Partners LLC lifted its holdings in shares of Haleon by 18.5% in the 3rd quarter. Hexagon Capital Partners LLC now owns 7,933 shares of the company’s stock worth $84,000 after purchasing an additional 1,238 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on HLN shares. UBS Group upgraded shares of Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Finally, Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $10.95.

Haleon Price Performance

Shares of NYSE HLN opened at $9.24 on Monday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. Haleon plc has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The stock has a market cap of $41.80 billion, a PE ratio of 27.16, a price-to-earnings-growth ratio of 2.52 and a beta of 0.29. The stock has a fifty day moving average of $9.54 and a 200-day moving average of $9.71.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.